Novo Nordisk Makes $5.2 Billion Acquisition Move
Danish pharmaceutical giant Novo Nordisk (NOVOb.CO) announced it has reached an agreement to acquire US-based Akero Therapeutics (AKRO.O) for up to $5.2 billion. This move will give Novo access to the experimental
